Avian influenza has been confirmed in birds, cattle, poultry, and humans in the U.S., heightening the urgency to support advanced preparedness in the event human-to-human transmission occurs. Alveo Technologies of Alameda, California, is a leader in decentralized molecular diagnostics, and is working to shift the paradigm of testing, monitoring and reporting for the early detection of pathogens so to minimize the destructive impact of viruses, fungi, bacteria and other pathogens. Joining us to talk about the importance of early detection for animals, humans and the environment is Shaun Holt, CEO of Alveo.